Customize the use of cookies

This website uses cookies to provide more efficient navigation and analyze visitor traffic. You will find detailed information about them below.

Cookies classified as "Necessary" will be stored in your browser, as they are essential for enabling the basic functionalities of the site. We also use third-party cookies aimed at analytics (Google Analytics), which help us analyze how you use this website. You can choose to enable or disable some of these cookies, but doing so may affect your browsing experience.

Always Active

These cookies are required to provide basic functionality of the website and cannot be disabled. They do not store any private or personally identifiable data.

These cookies allow us to understand how visitors interact with the website and provide information related to the number of visits, traffic sources, and bounce rates.

These cookies are used to provide visitors with personalized ads based on the pages they previously visited and to analyze the effectiveness of advertising campaigns. They are usually related to the integration of social media videos on the website.

cartif projects

CYTOPREP

Samples for analysis by flow cytometry (CMF)

Description

The objective of the CytoPrep project is the design and development of an integral solution consisting of new reagents, devices and equipment. Which are part of a new methodology for the preparation of samples for analysis by flow cytometry (CMF).

This new methodology will optimize sample preparation and assays, allowing specific identification in the patient´s blood sample of new markers, both at the cellular level, as at soluble level. These markers will be obtained simultaneously, with better sensitivity and reproducibility.

This innovative methodology will allow a diagnosis to be carried out:

  • More early and personalized.
  • On a wider variety of samples.
  • Minimize human errors.
  • Increase sensitivity, reproducibility and traceability.

Objectives

  • The development of this stabilizing solution that will allow maintaining protein and genetic expression profiles, in addition to intact cell characteristics during the pre-analytical phase.
  • The development and validation of antibodies against oncogenic markers, fusion proteins and normal differentiation markers.
  • The design and development of a reagent dispensing vial preloaded with reagent and easily integrated into a robotic system.

Actions

  • Filing of 3 patents.
  • Presentation of 2 scientific articles related to the results obtained from the application of the methodology.
  • The results will be presented at national congresses related to the subject of automation, robotics applied to rehbailitation, rehabilitation or robotics, such as “the national auto conference”, “CEA bioengineering symposium”, “national robotics conference”…

Expected Results

  • Protein preservation solution development, for analysis by CMF.
  • Development and validation of new AcMo against markers of clinical interest.
  • Design and development of a reagent dispensing vial, for CMF use.
  • Design and development of an automatic system for sample processing and test preparation.

Partners

Collaboration Challenges

RTC-2016-4707-1

CARTIF Total Budget: 156.046,96 €
CARTIF grant: 145,600.10 €
Duration: June 2016 – December 2018

Responsible

Rubén Alonso

Division of Industrial and Digital Systems

Networking

Health Projects:

ROSBAC

ROSBAC

The objective is to develop a new generation of Socio-Bio-Cooperative robotic devices based on haptic technology combined with the novel Socio-Bio-Cooperative control approach to robotic systems, which proposes to use the biophysical signals of the users to adapt their reaction to the user’s state.

read more
EIAROB

EIAROB

CARTIF PROJECTS EIAROBAmbient intelligence ecosystem for the support of long-term care at home using social botsDescriptionEIAROB project has as main objective promote the autonomy and quality life of elder and dependent people. The project is articulated in 3 axes:...

read more
PROCURA

PROCURA

PROCURA aims at the realisation of two innovative social and health care solutions for active ageing and independent living, going beyond the current specifications available on the market and allowing the piloting of innovative technologies in the experimental environment of a living lab.

read more
Share This